111 results
Page 3 of 6
8-K
EX-99.1
39psaviyc2e jwjuj
13 Sep 21
Results of Operations and Financial Condition
8:37am
POS AM
dbnpudtt7 iua4
21 May 21
Prospectus update (post-effective amendment)
5:09pm
8-K
EX-10.1
awh6flexd9144pa278l
3 May 21
Entry into a Material Definitive Agreement
6:06am
424B5
3cq hzdwb34nv
30 Apr 21
Prospectus supplement for primary offering
9:56pm
8-K/A
EX-99.2
tuu4hza67r0c8s
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K/A
EX-99.3
g16 s70xi8
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K
EX-99.2
cyu4wizi4j qks
9 Mar 21
ImmunityBio and NantKwest Complete Merger
9:58pm
8-K
EX-99.3
8p1fyr9yjomshot
9 Mar 21
ImmunityBio and NantKwest Complete Merger
9:58pm
DEFM14A
st0518q8z5exu
2 Feb 21
Proxy related to merger
6:10am
424B3
4jzh3eoi
2 Feb 21
Prospectus supplement
6:05am
S-4/A
fylharoq
29 Jan 21
Registration of securities issued in business combination transactions (amended)
5:01pm
S-4
kkdc5s9
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm
S-4
EX-10.19
t2eg0yoxp56kkw0obysg
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm
S-4
EX-10.12
ri6wjdb
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm